Clinical Trial Update: Evaluation of Serum Ceramides C16, C24, and Sphingosine-1-Phosphate (S1P) in Patients With Acne Vulgaris

View source ↗

Summary

A Sohag University‑sponsored clinical trial is evaluating serum ceramides C16 and C24 and sphingosine-1-phosphate as potential biomarkers in patients with acne …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Snippet

Sponsor: Sohag University | Conditions: Acne Vulgaris | Status: NOT_YET_RECRUITING